FindTrial
Sign In

Remifentanil - based anesthesia is superior to sufentanil in early recovery after laparoscopic hernia repair.

Remifentanil - based anesthesia is superior to sufentanil in early recovery after laparoscopic hernia repair.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027245
Enrollment
Unknown
Registered
2019-11-06
Start date
2020-01-01
Completion date
Unknown
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hernia

Interventions

1:Remifentanil
2:Suifentanyl

Sponsors

Xuzhou traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: The selected subjects were ASA grade I or grade II, aged between 18 and 70 years, and under general anesthesia, the patients with laparoscopic herniorrhaphy.

Exclusion criteria

Exclusion criteria: Reoperation; chronic liver and renal function disease; severe heart, lung, and other organ diseases; and remifentanil, sufentanil, and concomitant administration of the drug; not complete QoR-15 by poor understanding ability, mental abnormality or central nervous system disorder; Body mass index> 40% or <22%.

Design outcomes

Primary

MeasureTime frame
QoR-15;—

Countries

Chnia

Contacts

Public ContactLu Feifei

Department of Anesthesiology, Xuzhou Traditional Chinese Medicine Hospital

584481412@qq.com+86 18795425961

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026